Epicrispr Biotechnologies has raised $68m in the initial close of its Series B financing round to commence the clinical trial ...

Please provide your email address to receive an email when new articles are posted on . Treatment with losmapimod and placebo had similar results with respect to primary, secondary endpoints. No ...